Quiz
Quiz: Cost-Effectiveness of Venetoclax Plus Obinutuzumab for CLL
11/22/2021
Current Issue
August 2025
Volume 11
Issue 4
JCP Clinical Pathways Categories
Subscribe
Journal of Clinical Pathways Newsletter